These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
161 related articles for article (PubMed ID: 22294845)
1. A polymorphism within ErbB4 is associated with risk for hepatocellular carcinoma in Chinese population. Yu Q; Zhou CX; Chen NS; Zheng SD; Shen LM; Zhang JK World J Gastroenterol; 2012 Jan; 18(4):383-7. PubMed ID: 22294845 [TBL] [Abstract][Full Text] [Related]
2. An insertion/deletion polymorphism in the 3' untranslated region of type I collagen a2 (COL1A2) is associated with susceptibility for hepatocellular carcinoma in a Chinese population. Zhu Z; Jiang Y; Chen S; Jia S; Gao X; Dong D; Gao Y Cancer Genet; 2011 May; 204(5):265-9. PubMed ID: 21665180 [TBL] [Abstract][Full Text] [Related]
3. Genetic variation of ErbB4 confers risk of colorectal cancer in a Chinese Han population. Gao X; Zhang S; Zhu Z Cancer Biomark; 2014; 14(6):435-9. PubMed ID: 25335735 [TBL] [Abstract][Full Text] [Related]
4. Association between an insertion/deletion polymorphism within 3'UTR of SGSM3 and risk of hepatocellular carcinoma. Wang C; Zhao H; Zhao X; Wan J; Wang D; Bi W; Jiang X; Gao Y Tumour Biol; 2014 Jan; 35(1):295-301. PubMed ID: 23918301 [TBL] [Abstract][Full Text] [Related]
5. A miR-1231 binding site polymorphism in the 3'UTR of IFNAR1 is associated with hepatocellular carcinoma susceptibility. Zhou C; Yu Q; Chen L; Wang J; Zheng S; Zhang J Gene; 2012 Oct; 507(1):95-8. PubMed ID: 22824466 [TBL] [Abstract][Full Text] [Related]
6. An insertion/deletion polymorphism in the 3' untranslated region of beta-transducin repeat-containing protein (betaTrCP) is associated with susceptibility for hepatocellular carcinoma in Chinese. Chen S; He Y; Ding J; Jiang Y; Jia S; Xia W; Zhao J; Lu M; Gu Z; Gao Y Biochem Biophys Res Commun; 2010 Jan; 391(1):552-6. PubMed ID: 19931512 [TBL] [Abstract][Full Text] [Related]
7. An indel polymorphism in the 3' untranslated region of HMGB1 confers risk for hepatocellular carcinoma by regulating HMGB1 transcriptional activity in a Chinese population. Wang J; Zhu J; Mao DH; Zhu S; Mi XG; Yu Q Neoplasma; 2020 Jan; 67(1):61-67. PubMed ID: 31777261 [TBL] [Abstract][Full Text] [Related]
8. The mitochondrial DNA 9-bp deletion polymorphism is a risk factor for hepatocellular carcinoma in the Chinese population. Jin Y; Yu Q; Zhou D; Chen L; Huang X; Xu G; Huang J; Gao X; Gao Y; Shen L Genet Test Mol Biomarkers; 2012 May; 16(5):330-4. PubMed ID: 22283196 [TBL] [Abstract][Full Text] [Related]
9. A functional insertion/deletion polymorphism in the promoter of PDCD6IP is associated with the susceptibility of hepatocellular carcinoma in a Chinese population. Yu Q; Zhou C; Wang J; Chen L; Zheng S; Zhang J DNA Cell Biol; 2013 Aug; 32(8):451-7. PubMed ID: 23777424 [TBL] [Abstract][Full Text] [Related]
10. A 40-bp insertion/deletion polymorphism in the constitutive promoter of MDM2 confers risk for hepatocellular carcinoma in a Chinese population. Dong D; Gao X; Zhu Z; Yu Q; Bian S; Gao Y Gene; 2012 Apr; 497(1):66-70. PubMed ID: 22285926 [TBL] [Abstract][Full Text] [Related]
11. The 14bp-deletion allele in the HLA-G gene confers susceptibility to the development of hepatocellular carcinoma in the Brazilian population. Teixeira AC; Mendes-Junior CT; Souza FF; Marano LA; Deghaide NH; Ferreira SC; Mente ED; Sankarankutty AK; Elias-Junior J; Castro-e-Silva O; Donadi EA; Martinelli AL Tissue Antigens; 2013 Jun; 81(6):408-13. PubMed ID: 23506091 [TBL] [Abstract][Full Text] [Related]
12. Association of HLA-G 3' UTR 14-bp insertion/deletion polymorphism with hepatocellular carcinoma susceptibility in a Chinese population. Jiang Y; Chen S; Jia S; Zhu Z; Gao X; Dong D; Gao Y DNA Cell Biol; 2011 Dec; 30(12):1027-32. PubMed ID: 21612396 [TBL] [Abstract][Full Text] [Related]
13. A functional insertion/deletion polymorphism in the proximal promoter of CD3G is associated with susceptibility for hepatocellular carcinoma in Chinese population. Jiang L; Xu J; Ni J; Gao X; Zhu Z; Dong D; Wang X; Shi C; Tao X; Dong W; Gao Y DNA Cell Biol; 2012 Sep; 31(9):1480-5. PubMed ID: 22731821 [TBL] [Abstract][Full Text] [Related]
14. Relationship between polymorphism of angiotensin-converting enzyme gene insertion/deletion and risk of hepatocellular carcinoma in a Chinese Dai population. Zha Y; Gan P; Liu Q; Tan J J Renin Angiotensin Aldosterone Syst; 2015 Sep; 16(3):695-9. PubMed ID: 25208933 [TBL] [Abstract][Full Text] [Related]
15. Insertion/deletion polymorphisms in the promoter region of BRM contribute to risk of hepatocellular carcinoma in Chinese populations. Gao X; Huang M; Liu L; He Y; Yu Q; Zhao H; Zhou C; Zhang J; Zhu Z; Wan J; Jiang X; Gao Y PLoS One; 2013; 8(1):e55169. PubMed ID: 23359823 [TBL] [Abstract][Full Text] [Related]
16. Tumor-promoting function of single nucleotide polymorphism rs1836724 (C3388T) alters multiple potential legitimate microRNA binding sites at the 3'-untranslated region of ErbB4 in breast cancer. Bagheri F; Mesrian Tanha H; Mojtabavi Naeini M; Ghaedi K; Azadeh M Mol Med Rep; 2016 May; 13(5):4494-8. PubMed ID: 27035115 [TBL] [Abstract][Full Text] [Related]
17. A single nucleotide polymorphism in the promoter region (rs10877887) of let-7 is associated with hepatocellular carcinoma in a Chinese population. Sui ZY; Li J; Cheng GL; Wang SF Genet Mol Res; 2016 May; 15(2):. PubMed ID: 27323017 [TBL] [Abstract][Full Text] [Related]
18. A functional variant at miR-34a binding site in toll-like receptor 4 gene alters susceptibility to hepatocellular carcinoma in a Chinese Han population. Jiang ZC; Tang XM; Zhao YR; Zheng L Tumour Biol; 2014 Dec; 35(12):12345-52. PubMed ID: 25179842 [TBL] [Abstract][Full Text] [Related]
19. C-reactive protein genetic polymorphisms increase susceptibility to HBV-related hepatocellular carcinoma in a Chinese population. Peng Q; Ren S; Lao X; Lu Y; Zhang X; Chen Z; Qin X; Li S Tumour Biol; 2014 Oct; 35(10):10169-76. PubMed ID: 25027406 [TBL] [Abstract][Full Text] [Related]
20. [Relationship between genetic polymorphism in microRNAs precursor and genetic predisposition of hepatocellular carcinoma]. Zhang XW; Pan SD; Feng YL; Liu JB; Dong J; Zhang YX; Chen JG; Hu ZB; Shen HB Zhonghua Yu Fang Yi Xue Za Zhi; 2011 Mar; 45(3):239-43. PubMed ID: 21624236 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]